| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.094 | 0.05 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.05 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.05 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |